Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JTO Clinical and Research Reports|August 18, 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case ReportKen Yamamoto, Katsuya Hirano, Temiko Shimada, et al.
Internal Medicine (Tokyo, Japan)|April 4, 2002
Unusual swallow syncope caused by huge hiatal herniaToru Maekawa, Masakuni Suematsu, Temiko Shimada, et al.
Chest|March 16, 2006
Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndromeKazuyuki Kobayashi, Yoshihiro Nishimura, Temiko Shimada, et al.
Thoracic Cancer|April 16, 2024
Continuous immunotherapy beyond progression in clinical practice for small cell lung cancerKen Yamamoto, Taira Ninomaru, Hideaki Okada, et al.
The Kobe Journal of Medical Sciences|August 9, 2007
Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic changeTemiko Shimada, Yoshihiro Nishimura, Teruaki Nishiuma, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 12, 2018
Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case reportYukihisa Hatakeyama, Hisashi Ohnishi, Kentaro Suda, et al.
Medical Oncology (Northwood, London, England)|August 4, 2007
Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drugYoshiko Urata, Shunichi Negoro, Miyako Satouchi, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 23, 2003
[Pulmonary thromboembolism associated with familial protein C deficiency type I]Sho Yoshimura, Yoshihiro Nishimura, Yasuhiro Funada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2010
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancerMiyako Satouchi, Yoshikazu Kotani, Nobuyuki Katakami, et al.
Pageof 2